(Reuters) - GlaxoSmithKline Plc's cancer treatment Zejula met the main goal of helping patients with ovarian cancer live longer without their disease worsening in a late-stage study, the company said Monday.
Vyopta Secures $7.5 Million in Series B Funding from Elsewhere Partners to Optimize Workplace Collaboration
Company to Use Funds to Accelerate Market Penetration, Product Innovation and Leadership in Collaboration Monitoring and Analytics Vyopta, the leading developer of monitoring and analytics tools to optimize
BenevolentAI, a buzzy London tech startup trying to discover new drugs with artificial intelligence, is lowering its valuation, according to a report from The Times. Led by Baroness Joanna Shields, the
AstraZeneca has called for a wholesale review of the way new drugs are paid for in England and Wales after Nice refused to pay for one of its most important cancer medications. Nice, the government body